|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Option (Right to Buy) (4) | $ 53.53 | 11/20/2013 | A | 120,620 | 11/20/2014(5) | 11/19/2023 | Common Stock | 120,620 | $ 0 | 120,620 | D | ||||
Employee Stock Option (Right to Buy) (4) | $ 29.46 | 11/21/2013 | M | 28,207 | 11/18/2010(6) | 11/17/2019 | Common Stock | 28,207 | $ 0 | 0 | D | ||||
Employee Stock Option (Right to Buy) (4) | $ 35.84 | 11/21/2013 | M | 35,000 | 11/21/2013(5) | 11/20/2022 | Common Stock | 35,000 | $ 0 | 105,000 | D | ||||
Employee Stock Option (Right to Buy) (4) | $ 37.21 | 11/21/2013 | M | 28,174 | 11/17/2012(5) | 11/16/2021 | Common Stock | 28,174 | $ 0 | 56,349 | D | ||||
Employee Stock Option (Right to Buy) (4) | $ 35.21 | 11/21/2013 | M | 22,766 | 11/17/2011(5) | 11/16/2020 | Common Stock | 22,766 | $ 0 | 22,767 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Nersesian Ronald S. 5301 STEVENS CREEK BLVD. SANTA CLARA, CA 95051 |
Executive Vice President |
/s/ Stephen D. Williams, attorney-in-fact for Mr. Nersesian | 11/22/2013 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | On November 20, 2013, pursuant to the Agilent Technologies, Inc. Long-Term Performance Program, 18,831 shares of common stock of Agilent Technologies, Inc. were awarded to the reporting person. Under the Agilent Technologies, Inc. Deferred Compensation Plan, the reporting person has elected to defer 17,889 of such shares of common stock. |
(2) | The weighted average price was $54.39 with a range of $54.22 to $54.55 |
(3) | The reporting person surrendered 912 shares to Agilent to satisfy tax liability on the release of restricted shares in accordance with Rule 16b-3. |
(4) | Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3. |
(5) | The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated. |
(6) | The option is fully vested and exercisable |